[1]张平安,高娜,姚涛,等.基于网络药理学与GEO数据库探讨心瘅方治疗病毒性心肌炎的机制[J].西部中医药,2024,37(05):101-109.[doi:10.12174/j.issn.2096-9600.2024.05.19]
　ZHANG Ping'an,GAO Na,YAO Tao,et al.Exploration into the Mechanism of Xindan Formula (Heart-heat Formula) in the Treatment of Viral Myocarditis based on Network Pharmacology and GEO Database[J].Western Journal of Traditional Chinese Medicine,2024,37(05):101-109.[doi:10.12174/j.issn.2096-9600.2024.05.19]
点击复制

基于网络药理学与GEO数据库探讨心瘅方治疗病毒性心肌炎的机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年05期
页码:
101-109
栏目:
二次研究
出版日期:
2024-05-15

文章信息/Info

Title:
Exploration into the Mechanism of Xindan Formula (Heart-heat Formula) in the Treatment of Viral Myocarditis based on Network Pharmacology and GEO Database
作者:
张平安1, 高娜2, 姚涛2, 王国斌3, 车志英2
1.北京中医药大学，北京 100029
2.河南中医药大学，河南 郑州 450046
3.河南中医药大学第三附属医院，河南 郑州 450003
Author(s):
ZHANG Ping'an1, GAO Na2, YAO Tao2, WANG Guobin3, CHE Zhiying2
1.Beijing University of Chinese Medicine, Beijing 100029, China
2.Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
3.Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450003, China
关键词:
病毒性心肌炎; 网络药理学; GEO数据库; 靶基因; microRNA; 心瘅方
Keywords:
viral myocarditis; network pharmacology; GEO database; target genes; microRNA; formula
分类号:
R256.21
DOI:
10.12174/j.issn.2096-9600.2024.05.19
文献标志码:
A
摘要:
目的基于网络药理学与GEO数据库探讨心瘅方治疗病毒性心肌炎的microRNA-mRNA调控机制。 方法使用中药系统药理学数据库与分析平台（traditional Chinese medicine systems pharmacology database and analysis platform，TCMSP）筛选心瘅方中药物活性成分及其靶基因；利用GEO数据库筛选病毒性心肌炎与健康人的差异microRNA；利用FunRich3.1.3对差异microRNA进行mRNA富集，并与药物靶基因取交集基因；通过蛋白-蛋白互作网络（protein-protein interactions，PPI）以及cytoNCA筛选出核心基因；运用R软件对核心基因进行基因本体（gene ontology，GO）和京都基因与基因组百科全书（kyoto encyclopedia of genes and genomes，KEGG）通路富集分析。 结果心瘅方中药物活性成分共199个，潜在作用靶点490个，GEO数据库Series GSE148153符合要求，通过筛选得到差异microRNA 438个，50个microRNA与核心基因有对应关系，上调基因45个，下调基因5个；筛选得到交集基因207个，其中33个为核心基因；GO功能注释主要富集在肌细胞增殖、MAP激酶活性等生物学过程，并且主要富集在PI3K/Akt、人巨细胞病毒感染、白细胞介素17等信号通路。 结论心瘅方调控microRNA-mRNA过程治疗病毒性心肌炎与中药成分干预肌细胞增殖、MAP激酶活性等生物学过程和PI3K/Akt、人巨细胞病毒感染、肿瘤坏死因子信号通路等有关，此过程可能涉及hsa-miR-15b-5p和hsa-miR-21-5p等外泌体的表达。
Abstract:
ObjectiveTo investigate the microRNA-mRNA regulatory mechanism of Xindan formula (heart-heat formula) in the treatment of viral myocarditis based on network pharmacology and GEO database. MethodsThe TCMSP database was used to screen the active ingredients of the drugs and their target genes; the GEO database was utilized to search for differential microRNAs between viral myocarditis and healthy individuals; FunRich 3.1.3 was applied to perform mRNA enrichment of the differential microRNAs and take the intersecting genes with the target genes of the drugs; the core genes were screened by the PPI as well as cytoNCA; and the core genes were analyzed by GO and KEGG pathway enrichment using the R software. ResultsThere were 199 active ingredients and 490 potential targets in the herbs of Xindan formula, and the GEO database Series GSE148153 met the requirements. 438 differential microRNAs were obtained through screening, 50 microRNAs had correspondence with core genes, 45 up-regulated genes and five down-regulated genes; 207 intersecting genes were obtained through screening, 33 of which were core genes; GO functional annotations were mainly enriched in biological processes such as myoblast proliferation, MAP kinase activity, and mainly enriched in PI3K-Akt signaling pathway, human cytomegalovirus infection, and IL-17 signaling pathway. ConclusionThe process of Xindan formula regulating the microRNA-mRNA in the treatment of viral myocarditis is related to the intervention of herbal ingredients in biological processes such as myocyte proliferation, MAP kinase activity and PI3K-Akt, human cytomegalovirus infection, and tumor necrosis factor signaling pathway, etc., and this process may involve the expression of exosomes, such as hsa-miR-15b-5p and hsa-miR-21-5p, etc.

相似文献/References:

[1]冯珊珊.病毒性心肌炎合并Ⅲ度房室传导阻滞护理预防措施及效果[J].西部中医药,2015,28(08):164.
[2]陈士利.舒血宁治疗心肌炎60例临床观察[J].西部中医药,2014,27(04):92.
　CHEN Shili.Curative Observation on ShuXueNing Injection for 60 Cases of Viralmyocarditis[J].Western Journal of Traditional Chinese Medicine,2014,27(05):92.
[3]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
　TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[4]吴春凤,黄艳霞,郑景辉.基于网络药理学分析荆芥—防风药对的分子作用机制[J].西部中医药,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
　WU Chunfeng,HUANG Yanxia,ZHENG Jinghui.Molecular Mechanism of Couplet Medicinals Jingjie‐Fangfeng Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
[5]陶鑫,薛中峰,覃骊兰.基于网络药理学的过敏煎治疗过敏性哮喘分子机制研究[J].西部中医药,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
　TAO Xin,XUE Zhongfeng,QIN Lilan.Study on the Molecular Mechanism of Guomin Jian in the Treatment of Allergic Asthma Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
[6]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
　HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
[7]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
　SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(05):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[8]刘卓超,黄小靖,曾志聪.黄连生物碱改善心力衰竭的网络药理学机制研究[J].西部中医药,2022,35(04):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
　LIU Zhuochao,HUANG Xiaojing,ZENG Zhicong.Study on the Mechanism of Coptis Alkaloid in the Treatment of Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
[9]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
　ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[10]林鑫,刘阳,陈林伟,等.基于网络药理学探讨气血双补方抗慢性心力衰竭的作用机制[J].西部中医药,2022,35(06):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
　LIN Xin,LIU Yang,CHEN Linwei,et al.Study on the Mechanism of Qixue Shuangbu Prescription in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]

备注/Memo

备注/Memo:
张平安（1995—），男，硕士学位。研究方向：内科呼吸系统疾病研究。国家中医药管理局全国名老中医药专家传承工作室建设项目（国中医人教发〔2016〕42号）；2020年河南中医药大学重点学科建设项目（15102044-2020-2）。
更新日期/Last Update: 2024-05-15